New Mayo Clinic representatives named to National Comprehensive Cancer Network panels, committees

Joleen Hubbard, M.D. (HEMO ’12), Division of Medical Oncology, Department of Oncology at Mayo Clinic in Rochester, was appointed to serve as a Mayo Clinic representative on the NCCN Colon/Rectal/Anus Cancers Guidelines Panel. She is an associate professor of oncology in the Mayo Clinic College of Medicine and Science.

Mohamed Kharfan Dabaja, M.D., Division of Hematology and Medical Oncology, Department of Internal Medicine at Mayo Clinic in Florida, was appointed to serve as a Mayo Clinic representative on the NCCN Hematopoietic Stem Cell Transplant Guidelines Panel.

Robert McWilliams, M.D. (HEMO ’05, CTSA ’10, CTSC ‘10), Division of Medical Oncology, Department of Oncology at Mayo Clinic in Rochester, was appointed to serve as a Mayo Clinic alternate representative on the NCCN Best Practices Committee. He is an instructor in medicine and professor of oncology in the Mayo Clinic College of Medicine and Science.